Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Paola Mancino"'
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 16, Iss 3, Pp 297-299 (2012)
In this case, a new possible strategy for treatment of hepatitis C virus (HCV) relapsing patients is described. The target of anti-HCV therapy is sustained viral response, but strategies for improving sustained viral response in relapsing patients wo
Externí odkaz:
https://doaj.org/article/5f8934ab48974001baefaea7bee1acf1
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 2, Iss 1, Pp e2010003-e2010003 (2010)
Haematological abnormalities are common during combination antiviral therapy for chronic hepatitis C. Although dose reduction or discontinuation can easily treat these side effects, they can adversely affect the efficacy of combination antiviral ther
Externí odkaz:
https://doaj.org/article/091e2d688a13454ea3976ea549077f81
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 2, Iss 1, Pp e2010003-e2010003 (2010)
Haematological abnormalities are common during combination antiviral therapy for chronic hepatitis C. Although dose reduction or discontinuation can easily treat these side effects, they can adversely affect the efficacy of combination antiviral ther
Externí odkaz:
https://doaj.org/article/eb2471d05c4d4b53ba13dc43051e60d0
Autor:
Claudio Ucciferri, Katia Falasca, Paola Mancino, Roberto Tommasi, Alfonso Tatasciore, Jacopo Vecchiet
Publikováno v:
Southern African Journal of HIV Medicine, Vol 12, Iss 1, Pp 41-42 (2011)
Case study
Externí odkaz:
https://doaj.org/article/4810badcf2d1466c85a62b1c94416536
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 16, Iss 3, Pp 297-299
In this case, a new possible strategy for treatment of hepatitis C virus (HCV) relapsing patients is described. The target of anti-HCV therapy is sustained viral response, but strategies for improving sustained viral response in relapsing patients wo
Externí odkaz:
https://doaj.org/article/6c62bd29a2e94669851c813997e0cb1e
Autor:
Jacopo Vecchiet, Maria Bianchi, Eugenia Rosa Nuzzolo, Katia Falasca, Luigi Maria Larocca, Maria Grazia Iachininoto, Maurizio Martini, Luciana Teofili, Paola Mancino, Antonio Maria Leone, Claudio Ucciferri, Sara Capodimonti
Publikováno v:
Thrombosis Research. 131:238-243
Background HIV infection is an independent risk factor for cardiovascular disease. HIV-sustained impairment of endothelial progenitor cells (EPCs) could contribute to this process, so that it is important to assess whether antiviral therapy (ART) is
Autor:
Claudio Ucciferri, Jacopo Vecchiet, Valeria Gorgoretti, Paola Mancino, Katia Falasca, Eligio Pizzigallo
Publikováno v:
Journal of Medical Virology. 82:49-56
The aim of the study was to evaluate the effects of epoetin-beta on anemia and sustained viral response in patients with chronic hepatitis C receiving treatment with pegylated interferon and ribavirin. Forty-two Caucasian patients with chronic hepati
Publikováno v:
International Journal of Immunopathology and Pharmacology. 22:853-857
In HIV-infected patients with metabolic disorders, as in the general population, there is evidence of hypertension requiring pharmacological treatment. The presence of diabetes constitutes a cluster of particularly high cardiovascular risks in patien
Publikováno v:
Scandinavian Journal of Infectious Diseases. 40:67-73
Linezolid is not yet recognized as a standard therapy for infective endocarditis but its use becomes a necessity when infection is due to multidrug-resistant microorganisms. This report describes 1 patient with endocarditis treated with linezolid and
Autor:
P. Cacciatore, Delia Racciatti, M. Dalessandro, Eligio Pizzigallo, Jacopo Vecchiet, Paola Mancino, P.E. Gallenga, Katia Falasca, Pompea Zingariello
Publikováno v:
European Journal of Inflammation, Vol 3 (2005)